Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy

Christian Manegold, Alex Adjei, Federico Bussolino, Federico Cappuzzo, Lucio Crino, Rafal Dziadziuszko, David Ettinger, Dean Fennell, Keith Kerr, Thierry Le Chevalier, Natasha Leighl, Mauro Papotti, Luis Paz-Ares, Maurice Perol, Solange Peters, Robert Pirker, Elisabeth Quoix, Martin Reck, Egbert Smit, Everett VokesNico van Zandwijk, Caicun Zhou

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Issue number6
Publication statusPublished - Jan 2016

Cite this